4577 Daito Pharmaceutical
- 2242
- -46-2.01%
Daito Pharmaceutical News
Daito Pharmaceutical: FY May 2024 Financial Results Report [Japan Standard] (consolidated)
Daito Pharmaceutical: Earnings reports supplementary explanation materials for May 2024 fiscal year.
Daito Pharmaceutical: Announcement of revised financial estimates.
Dite: Confirmation
Daito: Quarterly Report - 82nd Quarter 3rd Quarter (2023/12/01 - 2024/02/29)
Daito Pharmaceutical: Summary of Financial Results for the 3rd Quarter Ending May 2024 [Japanese GAAP] (Consolidated)
Daito Pharmaceutical: Supplementary explanation materials for the announcement of financial results for the 3rd quarter of the fiscal year ending 2024/5
Daito Pharmaceutical: Extraordinary Report
Daito Pharmaceutical: Confirmation letter
Daito Pharmaceutical: Quarterly Report - 2nd quarter of the 82nd period (2023/09/01 to 2023/11/30)
Daito Pharmaceutical: Summary of financial results for the 2nd quarter of the fiscal year ending May 2024 [Japanese GAAP] (consolidated)
Daito Pharmaceutical: Supplementary explanation materials for the announcement of financial results for the 2nd quarter of the fiscal year ending May 2024
Daito Pharmaceutical: Confirmation letter
Daito Pharmaceutical: Quarterly Report - 82nd Quarter (2023/06/01-2023/08/31)
Daito Pharmaceutical: Supplemental Explanatory Materials for the 1st Quarter Financial Results Announcement for the Fiscal Year Ending May 2024
Daito Pharmaceutical: Summary of Financial Results for the First Quarter Ending May 2024 [Japanese GAAP] (Consolidated)
Daito Pharmaceutical: Extraordinary Report
Daito Pharmaceutical: Confirmation letter
Daito Pharmaceutical: Securities Report - 81st Term (2022/06/01 - 2023/05/31)
Daito Pharmaceutical: Summary of Financial Results for the Fiscal Year Ending May 2023 [Japanese GAAP] (Consolidated)
Analysis
Price Target
No Data
